New York, January 21, 2026, 12:38 EST — During the regular session
- Thermo Fisher shares surged beyond a modest market bounce as investors gear up for next week’s earnings.
- A new SEC filing and a Goldman Sachs boost to the price target kept the spotlight on the stock.
- Investors are eyeing the company’s earnings release and conference call set for January 29 as the next key catalyst.
Thermo Fisher Scientific shares climbed roughly 1.6% to $628.63 by midday Wednesday, beating the wider market gains.
This shift is crucial as investors brace for the company’s quarterly report next week, where management’s comments on lab demand and pharma services usually steer the stock’s near-term trajectory.
This week, markets remain jittery, and defensive healthcare stocks are drawing interest despite the volatility. Thermo Fisher stands out, offering a mix of growth potential and stability.
On Tuesday, Goldman Sachs boosted its price target for Thermo Fisher to $710 from $685, maintaining a “buy” rating, MarketScreener reported. MarketScreener
In a separate filing Wednesday, the New York Stock Exchange alerted the SEC that Thermo Fisher’s 3.200% senior notes maturing in 2026 are being delisted or deregistered. This action concerns the debt instrument only, not Thermo Fisher’s common shares.
Peers showed strength too. Danaher climbed around 1.8%, while Agilent rose about 1.4%, indicating the boost wasn’t confined to just one name.
Waltham, Massachusetts-based Thermo Fisher sells lab equipment and offers services to drugmakers, including manufacturing support via its pharma services unit.
Speaking at last week’s J.P. Morgan Healthcare Conference, CEO Marc Casper highlighted a surge in customers pushing to shift production back to the U.S. “There’s a very big focus on reshoring more production and activity to the U.S.,” he noted. Reuters
But bulls should beware: if the company’s guidance signals caution on biotech and pharma spending, or if order trends vary significantly across regions, the stock’s pre-earnings rally could quickly lose steam.
Thermo Fisher is set to release earnings on January 29, ahead of the market open, followed by a conference call at 8:30 a.m. ET. Investors will focus on demand trends for lab tools, progress in pharma services, and insights into customer spending plans for 2026.
Related articles: NYSE:TMO
